The Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives, established in Denmark in 1924. Our vision is to improve people’s health and contribute to the sustainability of society and the planet. Through strategic grant giving, partnerships, and long-term investments, the Foundation seeks to generate impact that benefits both current and future generations. Community guidelines We welcome dialogue on our channels and value respectful engagement. However, we reserve the right to remove comments that are offensive, racist, sexist, discriminatory, spam, or otherwise inappropriate. Repeated violations may result in being blocked from our channels.
解鎖市場時間軸與訊號動態
過去 90 日內有 162 個訊號。
此公司進入各市場的次序 — 由最舊至最新
註冊以查看完整訊號動態
Novo Nordisk Foundation 的國際擴張與競爭對手的比較
Novo Nordisk Foundation你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Novo Nordisk Foundation你 | 4 | 0 | -72% | 162 | 11 |
Senior Digital Workplace Manager (Maternity Cover)
查看招聘Gentofte, Capital Region of Denmark, Denmark · 上星期
Kontorelever
查看招聘Gentofte, Capital Region of Denmark, Denmark · 3星期前
Student Assistant, Public Affairs
查看招聘Gentofte, Capital Region of Denmark, Denmark · 3星期前
We’re launching a new roadmap to help unlock the potential of regenerative medicine in Europe. Based on a major analysis, it sets out what it will take to move from strong science to real-world therapies that treat or even cure disease.Today, Europe has the scientific foundations to lead globally. But too often, new knowledge isn’t translated into startups, clinical programmes, and approved treatments.We commissioned an analysis of Europe’s regenerative medicine landscape to better understand wh ...
已結束
Novo Nordisk Foundation and Global Health EDCTP3 launch partnership to advance global health research - Novo Nordisk Fonden
已結束
From foundational mRNA breakthroughs to unlocking the genetic mysteries of rare diseases, recipients of the Novo Nordisk Foundation Prize for Biomedicine don’t just study human health - they revolutionize it.This prestigious award honors outstanding scientists whose pioneering research has led to major medical breakthroughs and life-saving clinical applications.If you know a visionary scientist whose work is fundamentally shifting the paradigm of biomedicine, their contributions deserve the glob ...
已結束INTREPID聯盟報告指出,14個高風險病毒家族中僅6個有8種病毒疾病進入臨床試驗,3個家族完全沒有抗病毒藥物開發,凸顯大流行準備的關鍵缺口。
諾和諾德基金會推出CardioMetabolic Bridge,一項泛歐洲倡議,通過資金和指導支持學術研究,加速心臟代謝疾病的藥物發現和治療開發。
由Lene B. Oddershede領導的諾和諾德基金會正投資於量子計算，用於醫療保健和藥物發現，長期視角約為10年。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Novo Nordisk Foundation 業務、市場及增長訊號的快速解答。
